Telik (TELK)

Add to Watchlists
Create an Alert
1.35 +0.00  +0.00% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
TELK Price Chart
View All Events

TELK Events

Date Type Description
May 10 Earnings Telik Announces First Quarter 2013 Financial Results.
View All Performance Charts

TELK Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Telik is up 8.00% over the last year vs S&P 500 Total Return up 23.54%, Acura Pharmaceuticals down 55.03%, and Emergent Health up 458.8%.

Get Quote for

Portfolio Strategies Featuring TELK

Did Telik make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

TELK Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Telik, Inc., is a clinical-stage drug development company focused on discovering and developing small molecule drugs to treat cancer.

Recent Quotes

Symbol Price Chg Chg % Market Cap
TELK 1.35 +0.00 +0.00% 6.187M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.